Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03262701 · ClinicalTrials.gov registry record · Phase 4
Adjunctive Hydrogen Peroxide for Periodontal Therapy
A Phase 4 study, sponsored by Loma Linda University.
- Terminated
- Registry status
- Phase 4
- Development phase
- 42
- Enrollment target
NCT03262701 is a Phase 4 study that was terminated before completion, run by Loma Linda University. The registered enrollment target is 42 participants.
The verdict
NCT03262701, a Phase 4 study, was terminated before completion, sponsored by Loma Linda University.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 42 participants
- Enrollment target
Study Summary
There have been many adjunctive treatments for the additional clinical benefits to scaling and root planing (SRP) in the treatment of chronic periodontitis. Topical hydrogen peroxide (HP) delivered in a custom fabricated tray has been shown to improve pocket depth (PD) and inflammation. The purpose of this study is to assess the adjunctive treatment outcome of HP gel in custom tray application in individuals with chronic periodontitis receiving SRP. The purpose of this investigator-initiated study is to evaluate and compare the clinical effects of scaling and root planing (SRP) combined with local delivery of 1.7% hydrogen peroxide (HP) gel in customized trays to that of SRP alone.
Interventions
- DRUG Hydrogen Peroxide Gel, 13 weeks
- DRUG Hydrogen Peroxide Gel, 26 weeks
- OTHER Scaling and Root planing group
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2018-04-02 |
| Est. Completion | 2021-02-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03262701
The ClinicalTrials.gov registry entry for NCT03262701 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Loma Linda University, which has 237 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Hydrogen Peroxide Gel, 13 weeks is the first listed.
NCT03262701 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03262701 about?
NCT03262701 is a clinical study titled "Adjunctive Hydrogen Peroxide for Periodontal Therapy". There have been many adjunctive treatments for the additional clinical benefits to scaling and root planing (SRP) in the treatment of chronic periodontitis. Topical hydrogen peroxide (HP) delivered in a custom fabricated tray has been shown to improve pocket depth (PD) and inflammation. The purpose ...
What is the current status of trial NCT03262701?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 42 participants. The study started on 2018-04-02. Estimated completion is 2021-02-08.
What interventions are being tested in trial NCT03262701?
The interventions under investigation include: Hydrogen Peroxide Gel, 13 weeks (DRUG), Hydrogen Peroxide Gel, 26 weeks (DRUG), Scaling and Root planing group (OTHER).
Who is sponsoring clinical trial NCT03262701?
This trial is sponsored by Loma Linda University, which has 237 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.